We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Avanos Medical Inc (AVNS) USD0.01

Sell:$15.99 Buy:$16.00 Change: $0.01 (0.06%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$15.99
Buy:$16.00
Change: $0.01 (0.06%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$15.99
Buy:$16.00
Change: $0.01 (0.06%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.

Contact details

Address:
5405 Windward Parkway, Suite 100 South
ALPHARETTA
30004
United States
Telephone:
+1 (678) 4259273
Website:
https://avanos.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AVNS
ISIN:
US05350V1061
Market cap:
$736.23 million
Shares in issue:
45.96 million
Sector:
Health Care Supplies
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Michael Greiner
    Interim Chief Executive Officer, Senior Vice President, Chief Transformation Officer
  • Warren Machan
    Interim Chief Financial Officer
  • Mojirade James
    Senior Vice President, General Counsel, Secretary
  • Sigfrido Delgado
    Senior Vice President - Integrated Supply Chain
  • Kerr Holbrook
    Senior Vice President, Chief Commercial Officer
  • Sudhakar Varshney
    Senior Vice President - Global Supply Chain and Procurement

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.